Disruption of TGFbeta signaling pathways in human pancreatic cancer cells

D M Simeone1, T Pham, C D Logsdon

  • 1Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA. simeone@umich.edu

Annals of Surgery
|June 22, 2000
PubMed
Abstract

Insights

Transforming growth factor beta (TGFbeta) signaling is disrupted in pancreatic cancer cells, with Smad4 playing a key role in restoring TGFbeta responsiveness and suggesting its importance in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor beta (TGFbeta) is a known inhibitor of pancreatic cell growth.
  • Disruption of the TGFbeta signaling pathway is implicated in pancreatic cancer development.

Purpose of the Study:

  • To investigate TGFbeta signaling disruption in human pancreatic cancer cells.
  • To determine the roles of TGFbeta receptors and Smad genes in this process.

Main Methods:

  • Evaluated TGFbeta effects on pancreatic cancer cell lines (BxPC-3, MiaPaCa-2, PANC-1) using [3H]thymidine incorporation and reporter assays.
  • Assessed TGFbeta receptor and Smad 2/3 expression via cross-linking and RT-PCR.
  • Investigated restoration of TGFbeta responsiveness through transfection of signaling components.

Main Results:

  • Pancreatic cancer cell lines exhibited minimal inhibition of DNA synthesis and no reporter activation by TGFbeta.
  • TGFbeta receptors and Smad 2/3 transcripts were present.
  • Transfection of TGFbeta receptors or Smads 2/3 did not restore TGFbeta responsiveness.
  • Transfection of Smad4 restored TGFbeta responsiveness in the BxPC-3 cell line.

Conclusions:

  • Pancreatic cancer cells demonstrate a loss of TGFbeta responsiveness.
  • Smads 2/3 and TGFbeta receptors are not defective in the studied cell lines.
  • Smad4 plays a crucial role in restoring TGFbeta responsiveness in pancreatic cancer, indicating its significance.
  • Other unidentified genes likely contribute to TGFbeta resistance in pancreatic cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...